Cargando…

Ocular side effects of Trametinib and Dabrafenib: a case report

A 53-year-old man who has stage 4 non-small cell lung carcinoma and treated with Dabrafenib-Trametinib combination chemotherapy; presented with decreased bilateral visual acuity. We checked out slit lamp examination, fundoscopy, optical coherence tomography and fundus fluorescein angiography. In sli...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarım, Bilge, Kılıç, Meltem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097848/
https://www.ncbi.nlm.nih.gov/pubmed/37046057
http://dx.doi.org/10.1186/s12348-023-00339-0
_version_ 1785024657920884736
author Tarım, Bilge
Kılıç, Meltem
author_facet Tarım, Bilge
Kılıç, Meltem
author_sort Tarım, Bilge
collection PubMed
description A 53-year-old man who has stage 4 non-small cell lung carcinoma and treated with Dabrafenib-Trametinib combination chemotherapy; presented with decreased bilateral visual acuity. We checked out slit lamp examination, fundoscopy, optical coherence tomography and fundus fluorescein angiography. In slit lamp biomicroscopy; bilateral posterior synechiae, granulomatous keratic precipitates and + 4 cells in the anterior chamber were detected. Cystoid macular edema and subretinal fluid accumulation were revealed in optical coherence tomography. Dabrafenib and Trametinib treatments were discontinued and systemic methylprednisolone, topical corticosteroid and topical cyclopentolate were started. His best corrected visual acuity was increased from counting fingers from 2 m to 0,9 bilaterally and cystoid macular edema and serous retinal detachment were completely regressed as a result of systemic and topical corticosteroid treatment.
format Online
Article
Text
id pubmed-10097848
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-100978482023-04-14 Ocular side effects of Trametinib and Dabrafenib: a case report Tarım, Bilge Kılıç, Meltem J Ophthalmic Inflamm Infect Brief Report A 53-year-old man who has stage 4 non-small cell lung carcinoma and treated with Dabrafenib-Trametinib combination chemotherapy; presented with decreased bilateral visual acuity. We checked out slit lamp examination, fundoscopy, optical coherence tomography and fundus fluorescein angiography. In slit lamp biomicroscopy; bilateral posterior synechiae, granulomatous keratic precipitates and + 4 cells in the anterior chamber were detected. Cystoid macular edema and subretinal fluid accumulation were revealed in optical coherence tomography. Dabrafenib and Trametinib treatments were discontinued and systemic methylprednisolone, topical corticosteroid and topical cyclopentolate were started. His best corrected visual acuity was increased from counting fingers from 2 m to 0,9 bilaterally and cystoid macular edema and serous retinal detachment were completely regressed as a result of systemic and topical corticosteroid treatment. Springer Berlin Heidelberg 2023-04-12 /pmc/articles/PMC10097848/ /pubmed/37046057 http://dx.doi.org/10.1186/s12348-023-00339-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Brief Report
Tarım, Bilge
Kılıç, Meltem
Ocular side effects of Trametinib and Dabrafenib: a case report
title Ocular side effects of Trametinib and Dabrafenib: a case report
title_full Ocular side effects of Trametinib and Dabrafenib: a case report
title_fullStr Ocular side effects of Trametinib and Dabrafenib: a case report
title_full_unstemmed Ocular side effects of Trametinib and Dabrafenib: a case report
title_short Ocular side effects of Trametinib and Dabrafenib: a case report
title_sort ocular side effects of trametinib and dabrafenib: a case report
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097848/
https://www.ncbi.nlm.nih.gov/pubmed/37046057
http://dx.doi.org/10.1186/s12348-023-00339-0
work_keys_str_mv AT tarımbilge ocularsideeffectsoftrametinibanddabrafenibacasereport
AT kılıcmeltem ocularsideeffectsoftrametinibanddabrafenibacasereport